AMA CPT® Assistant - 2017 Issue 8 (August)

Pathology and Laboratory: Molecular Pathology (Q&A) (August 2017)

August 2017 page 10 Pathology and Laboratory: Molecular Pathology Question: A patient had a thromboembolic event and was placed on a newer oral anticoagulant (eg, dabigatran, rivaroxaban). The physician wishes to evaluate the patient for venous thrombophilia risk factors. The new oral anticoagulants interfere with these assays and may cause false positive results. Therefore, an "in vitro" neutralization method is used to eliminate interference to obtain accurate thrombophilia assessments so that the patient does not need to discontinue treatment. Is it appropriate to report code 85525, Heparin neutralization, for assays that eliminate interference from other anticoagulants, as this is...

To read the full article, sign in and subscribe to the AMA CPT® Assistant.


Access to this feature is available in the following products:
  • AMA's CPT® Assistant - Current + Archives
  • AMA's CPT® Advanced Coding Pack
CPT® Assistant content is the official source for CPT® coding guidance. It is an instrumental tool when appealing insurance denials and validating coding to auditors. Monthly issues and an extensive archive provide comprehensive guidance on proper CPT® coding for past, present and upcoming code set releases. Archives date back to 1990 for historical use of codes, changes, rationales, coding tips and trends in the industry.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.